Drug Origin Transparency Act of 2026
119-HR-8339119th CongressIntroduced Apr 16, 2026Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Matsui, Doris O. [D-CA-7](D-CA-7)3 cosponsors
Actions (3)
Referred to the House Committee on Energy and Commerce.
Apr 16, 2026House floor actions
Introduced in House
Apr 16, 2026Library of Congress
Introduced in House
Apr 16, 2026Library of Congress